ArticleBritish journal of cancer2022

Phase I study of nab-paclitaxel-based induction followed by nab-paclitaxel-based concurrent chemotherapy and re-irradiation in previously treated head and neck squamous cell carcinoma.

Ari J Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.